SFEBES2022 Poster Presentations Endocrine Cancer and Late Effects (14 abstracts)
The incidence and clinical significance of metabolically active brown adipose tissue in patients with pheochromocytomas and paragangliomas: A retrospective cohort study, systematic review and meta-analysis
Michael Onyema 1 , Eduard Ostarijas 2 , Raisa Minhas 1 , Aparajita Roy 1 , Jessica Kearney 1 , Asma Omran 3 , Zoulikha Zair 1 , Saira Reynolds 1 , Nicola Mulholland 1 , Benjamin Corcoran 1 , Mohammad Halim 1 , Simon Aylwin 1 & Georgios K Dimitriadis 1,3
1King’s College Hospital NHS Foundation Trust, London, United Kingdom; 2University of Pecs Medical School, Pecs, Hungary; 3King’s College London, London, United Kingdom
There is limited research into the impact of active brown adipose tissue (aBAT) in patients with phaeochromocytomas and paragangliomas (PPGLs). A small body of evidence has shown that patients with PPGL patients can exhibit a high prevalence for aBAT recognized as ranging between 8 - 28% without specific correlation to germline mutations. Furthermore, it has been suggested that aBAT may be linked to increased mortality. Systematic searches of the Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica (EMBASE), Cochrane Central Register of Controlled Trials (CENTRAL), EudraCT, ClinicalTrials.gov, medRvix CINAHL and Scopus databases were conducted. Our study was registered with PROSPERO international registry for systematic reviews with ID: CRD42021276073. Furthermore, we conducted a retrospective cohort study evaluating our records for patients between 2013-2021 with PPGLs who had an 18F-FDG PET/CT and metabolically aBAT. Meta-analytical calculations were performed using R software and SPSS was used for analyses of variables from our retrospective cohort study. Our systematic search produced 4 studies, the data of which were pooled into a meta-analysis including the data from our study. Our meta-analysis demonstrated a significant correlation between 18F-FDG PET/CT avidity and concentration of plasma metanephrines and normetanephrines using a random effect model (P<0.05). A total of 61 patients with PPGLs and 18F-FDG PET/CT were identified of which 8 (13%) had metabolically aBAT. A statistically significant correlation between SUVmax levels and number of locations with active BAT (r=0.822, P=0.012) was observed. A statistically significant difference in metadrenaline levels between mutational status clusters (Kruskal-Wallis statistic = 11.435, df = 2, P=0.003) with post-hoc analysis suggesting significant difference between clusters 1 (SDH/VHL) and 2 (MEN/RET), as well as between cluster 1 and control group. Patients with PPGLs exhibit a high prevalence of BAT activation on 18F-FDG PET/CT.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more